Jonathan Butcher, the Joseph N. Pew Jr. Professor in Engineering in the Meinig School of Biomedical Engineering, has been named this year’s recipient of the Kaplan Family Distinguished Faculty Fellowship from the Einhorn Center.
Weill Cornell Medicine researchers have demonstrated, for the first time, that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an “identity crisis.”
As states reassess Medicaid coverage following recent federal policy changes and the end of pandemic-era protections, researchers are advocating for evidence-based health care policy reform and expanded Medicaid coverage for children.
Thirty student startups received Human Spirit, Beck Fellows and Cane Entrepreneurial Scholars awards this summer from Entrepreneurship at Cornell, funding that will allow students to work on their startups rather than take traditional summer positions.
Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body’s defense systems, according to a study led by investigators at Weill Cornell Medicine.
A new study helps resolve a long-standing paradox in biology about genome architecture and cell function, which may provide insights into certain developmental disorders and cancers.
Researchers at Cornell University have developed a powerful new genetic toolkit that allows scientists to study how genes function at the level of individual cells, an advance that could accelerate discoveries in development, neuroscience and disease.
Personalized approaches have dramatically improved outcomes for many patients with non-Hodgkin B-cell lymphomas yet the same is not true for patients with more rare lymphoma types that originate in T cells.